CD8A and lung carcinoma: Herein, we employed Scm6A to further explore the m6A landscapes of exhausted CD8+ T cells and other cell types across different lung cancer subtypes, including lung squamous carcinoma (LUSC) (Figure 5A) and non-small cell lung cancer (NSCLC) (Figure 5B).